Back to search
Wound Chronic Draining
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Wound Chronic Draining trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Wound Chronic Draining trials you may qualify forTo determine the utility of tissue plasminogen activator (tPA) in the clearance of chronic subdural hematomas (CSDH). Intra-catheter tPA will be administered du…
Platelet-based therapies have been used to treat bony and soft tissue effects for more than 30 years. Tropocells® Autologous Platelet-Rich Fibrin (PRF) is being…
The RESPOND Registry is an observational study to assess the impact of PuraPly™ AM on the management of wounds in real world clinical settings; no experimental…
This is a 3 to 4 months, multi-site, prospective randomized clinical study of patients diagnosed with a chronic wound. The primary objective is to assess change…
The purpose of this study was to pursue statistical analysis on a series of molecular laboratory results obtained from chronic wounds. It elucidated diversity,…